MW4082A1 - Pharmaceutical formulations comprising human insulin and human proinsulin - Google Patents
Pharmaceutical formulations comprising human insulin and human proinsulinInfo
- Publication number
- MW4082A1 MW4082A1 MW40/82A MW4082A MW4082A1 MW 4082 A1 MW4082 A1 MW 4082A1 MW 40/82 A MW40/82 A MW 40/82A MW 4082 A MW4082 A MW 4082A MW 4082 A1 MW4082 A1 MW 4082A1
- Authority
- MW
- MALAWI
- Prior art keywords
- human
- pharmaceutical formulations
- proinsulin
- insulin
- human insulin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29671481A | 1981-08-27 | 1981-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW4082A1 true MW4082A1 (en) | 1984-06-13 |
Family
ID=23143234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW40/82A MW4082A1 (en) | 1981-08-27 | 1982-08-24 | Pharmaceutical formulations comprising human insulin and human proinsulin |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4652547A (xx) |
| JP (1) | JPS5846025A (xx) |
| AU (1) | AU551733B2 (xx) |
| BE (1) | BE894188A (xx) |
| CA (1) | CA1176161A (xx) |
| CH (1) | CH650678A5 (xx) |
| DE (1) | DE3232033A1 (xx) |
| DO (1) | DOP1982004086A (xx) |
| FR (1) | FR2511867B1 (xx) |
| GB (1) | GB2105191B (xx) |
| IL (1) | IL66613A (xx) |
| IT (1) | IT1153181B (xx) |
| LU (1) | LU84356A1 (xx) |
| MW (1) | MW4082A1 (xx) |
| NL (1) | NL8203314A (xx) |
| NZ (1) | NZ201686A (xx) |
| PH (1) | PH18725A (xx) |
| SE (1) | SE8204874L (xx) |
| ZA (1) | ZA826158B (xx) |
| ZW (1) | ZW17582A1 (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP1982004086A (es) * | 1981-08-27 | 1988-03-22 | Lilly Co Eli | Formula farmaceutica que comprende insulina humana y proinsulina humana |
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| US4992417A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogues |
| US4992418A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
| DE3827533A1 (de) * | 1988-08-13 | 1990-02-15 | Hoechst Ag | Pharmazeutische zubereitung zur behandlung des diabetes mellitus |
| ATE197067T1 (de) * | 1989-04-07 | 2000-11-15 | Cancerforskningsfonden Af 1989 | Plasminogen-aktivator-rezeptor vom urokinasetyp |
| US5208217A (en) * | 1989-04-20 | 1993-05-04 | Mount Sinai School Of Medicine Of The City University Of New York | Hepatospecific insulin analogues |
| WO1997011959A1 (en) * | 1995-09-29 | 1997-04-03 | Receptron, Inc. | Biologically active mhc peptides having a repeated amino acid sequence motif |
| CN101045166A (zh) | 2001-05-21 | 2007-10-03 | 耐科塔医药公司 | 化学修饰胰岛素的肺部给药 |
| BR0212522A (pt) | 2001-09-14 | 2004-08-10 | Novo Nordisk As | Ligando de ligação de zinco, hexâmero de insulina, preparação aquosa de insulina e métodos de prolongar a ação de uma preparação de insulina e de preparar um ligando de ligação de zinco |
| US7670984B2 (en) * | 2006-01-06 | 2010-03-02 | Headwaters Technology Innovation, Llc | Hydrocarbon-soluble molybdenum catalyst precursors and methods for making same |
| IL186598A0 (en) * | 2007-10-11 | 2008-11-03 | Mohammad Abdulrazik | Composition and method for the treatment or prevention of glaucoma and ocular hypertension |
| US9939551B2 (en) | 2012-09-24 | 2018-04-10 | Schlumberger Technology Corporation | Systems, devices and methods for borehole gravimetry |
| US20150366946A1 (en) * | 2013-01-29 | 2015-12-24 | Oshadi Drug Administration Ltd. | Pharmaceutical compositions for oral treatment of diabetes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4183849A (en) * | 1975-01-15 | 1980-01-15 | Nordisk Insulinlaboratorium | Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect |
| DOP1982004086A (es) * | 1981-08-27 | 1988-03-22 | Lilly Co Eli | Formula farmaceutica que comprende insulina humana y proinsulina humana |
-
1982
- 1982-08-17 DO DO1982004086A patent/DOP1982004086A/es unknown
- 1982-08-23 IL IL66613A patent/IL66613A/xx unknown
- 1982-08-23 ZW ZW175/82A patent/ZW17582A1/xx unknown
- 1982-08-23 CA CA000409933A patent/CA1176161A/en not_active Expired
- 1982-08-23 CH CH5009/82A patent/CH650678A5/de not_active IP Right Cessation
- 1982-08-24 BE BE6/47704A patent/BE894188A/fr not_active IP Right Cessation
- 1982-08-24 NL NL8203314A patent/NL8203314A/nl not_active Application Discontinuation
- 1982-08-24 NZ NZ201686A patent/NZ201686A/en unknown
- 1982-08-24 ZA ZA826158A patent/ZA826158B/xx unknown
- 1982-08-24 MW MW40/82A patent/MW4082A1/xx unknown
- 1982-08-24 PH PH27770A patent/PH18725A/en unknown
- 1982-08-25 FR FR8214594A patent/FR2511867B1/fr not_active Expired
- 1982-08-25 SE SE8204874A patent/SE8204874L/ unknown
- 1982-08-25 JP JP57148495A patent/JPS5846025A/ja active Pending
- 1982-08-25 AU AU87596/82A patent/AU551733B2/en not_active Ceased
- 1982-08-26 GB GB08224486A patent/GB2105191B/en not_active Expired
- 1982-08-26 LU LU84356A patent/LU84356A1/fr unknown
- 1982-08-27 IT IT23016/82A patent/IT1153181B/it active
- 1982-08-27 DE DE19823232033 patent/DE3232033A1/de not_active Withdrawn
-
1984
- 1984-12-17 US US06/682,207 patent/US4652547A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB2105191A (en) | 1983-03-23 |
| LU84356A1 (fr) | 1983-02-28 |
| IL66613A0 (en) | 1982-12-31 |
| CH650678A5 (de) | 1985-08-15 |
| FR2511867A1 (fr) | 1983-03-04 |
| DOP1982004086A (es) | 1988-03-22 |
| SE8204874D0 (sv) | 1982-08-25 |
| IL66613A (en) | 1985-11-29 |
| AU8759682A (en) | 1983-03-03 |
| ZA826158B (en) | 1984-04-25 |
| DE3232033A1 (de) | 1983-03-10 |
| JPS5846025A (ja) | 1983-03-17 |
| CA1176161A (en) | 1984-10-16 |
| IT1153181B (it) | 1987-01-14 |
| ZW17582A1 (en) | 1982-11-17 |
| NL8203314A (nl) | 1983-03-16 |
| SE8204874L (sv) | 1983-02-28 |
| BE894188A (fr) | 1983-02-24 |
| IT8223016A0 (it) | 1982-08-27 |
| NZ201686A (en) | 1985-08-30 |
| AU551733B2 (en) | 1986-05-08 |
| US4652547A (en) | 1987-03-24 |
| PH18725A (en) | 1985-09-11 |
| GB2105191B (en) | 1984-12-19 |
| FR2511867B1 (fr) | 1986-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL79887A (en) | Human insulin analogues,their preparation and pharmaceutical compositions containing them | |
| GB2105191B (en) | Pharmaceutical formulations comprising human insulin and human proinsulin | |
| GB2104382B (en) | Pharmaceutical formulations comprising human insulin and human c-peptide | |
| AU549066B2 (en) | Preparation of human insulin | |
| GB2106115B (en) | Pharmaceutical amides, and preparation, formulations and use thereof | |
| GB2104380B (en) | Human proinsulin pharmaceutical formulations | |
| ZW17682A1 (en) | Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin | |
| ZA827001B (en) | Pharmaceutical amides,and preparation,formulations and use thereof | |
| JPS57209227A (en) | Insulin medicine and manufacture | |
| JO1209B1 (en) | Pharmacy formulations that include human insulin and the human insulin component. | |
| IE812104L (en) | Novel insulin formulations based on human insulin | |
| IE822065L (en) | Insulin and proinsulin formulations | |
| JO1238B1 (en) | Pharmacy formulations include human insulin, human peptide-C and the human insulin component | |
| JO1236B1 (en) | Pharmacy formulations that include human insulin and a human-c-peptide |